Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Qualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference

Advancing Data Center AI Infrastructure” – emphasizes the strategic leap in Qualcomm’s architecture for enterprise-scale AI Qualcomm Technologies, Inc. has announced the launch of its next-generation AI inference-optimized solutions for data centers: the Qualcomm® AI200 and Qualcomm® AI250 chip-based accelerator…

Read MoreQualcomm Launches AI200 and AI250, Setting a New Standard for Rack-Scale AI Inference
Chemetall

IMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025

IMCD Showcases Greener, Smarter, and Patient-Centric Pharmaceutical Innovations at CPHI Frankfurt 2025 a global leader in the distribution and formulation of specialty chemicals and ingredients, has announced its participation at CPHI Frankfurt 2025, taking place from 28–30 October. At this…

Read MoreIMCD Unveils Greener, Smarter, Patient-Centric Solutions at CPHI Frankfurt 2025
Evonik

Chemetall and Londian Wason Partner on New Chromium- and Fluoride-Free Copper Foil Tech

Chemetall and Londian Wason Form Strategic Partnership to Advance Sustainable Copper Foil Technologies for the Next Generation of Energy Solutions Chemetall, a leading global provider of innovative surface treatment solutions and the Surface Treatment business unit of BASF Coatings, has…

Read MoreChemetall and Londian Wason Partner on New Chromium- and Fluoride-Free Copper Foil Tech

Arrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis

Arrowhead Pharmaceuticals Announces Completion of Global Licensing and Collaboration Agreement with Novartis Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a leading biopharmaceutical company focused on developing innovative RNA interference (RNAi) therapeutics, announced today that its previously disclosed global licensing and collaboration agreement…

Read MoreArrowhead Pharmaceuticals Finalizes Global Licensing and Collaboration Deal with Novartis